Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
NCT ID: NCT07176130
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2025-08-19
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers of Common Eye Diseases
NCT04101604
Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders
NCT03594370
Quality of Life and Visual Function in Uveitis Patients
NCT00407316
Clinical Features and Visual Prognosis of Infectious Endophthalmitis
NCT06755177
Myopic Macular Haemorrhages
NCT00345228
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uveitis
Patients diagnosed with uveitis at Singapore National Eye Centre
No Intervention: Observational Cohort
Not applicable, No intervention. Observational study.
Scleritis and Episcleritis
Patients diagnosed with scleritis or episcleritis at Singapore National Eye Centre
No Intervention: Observational Cohort
Not applicable, No intervention. Observational study.
Intraocular lymphoma
Patients diagnosed with ocular neoplasms at Singapore National Eye Centre
No Intervention: Observational Cohort
Not applicable, No intervention. Observational study.
Endophthalmitis
Patients diagnosed with endophthalmitis at Singapore National Eye Centre
No Intervention: Observational Cohort
Not applicable, No intervention. Observational study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention: Observational Cohort
Not applicable, No intervention. Observational study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with scleritis or episcleritis
* Patients diagnosed with ocular neoplasms e.g., vitreoretinal and uveal lymphoma
* Patients diagnosed with endophthalmitis
* Diagnosis confirmed by laboratory testing or histopathological examination
* Patients diagnosed and managed at the Singapore National Eye Centre (SNEC)
Exclusion Criteria
* Patients with incomplete diagnostic confirmation (i.e., lacking laboratory or histopathological evidence)
* Patients diagnosed outside of Singapore National Eye Centre (SNEC)
* Cases with missing key clinical or outcome data
21 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore National Eye Centre
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samanthila Waduthantri
Principal Resident Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore National Eye Centre
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Siak J, Jansen A, Waduthantri S, Teoh CS, Jap A, Chee SP. The Pattern of Uveitis among Chinese, Malays, and Indians in Singapore. Ocul Immunol Inflamm. 2017;25(sup1):S81-S93. doi: 10.1080/09273948.2016.1188968. Epub 2016 Jul 15.
Chee SP, Jap A. Endogenous endophthalmitis. Curr Opin Ophthalmol. 2001 Dec;12(6):464-70. doi: 10.1097/00055735-200112000-00012.
International Vitreoretinal B-Cell Lymphoma Registry Investigator Group. Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma. Ophthalmol Retina. 2024 Jan;8(1):72-80. doi: 10.1016/j.oret.2023.08.012. Epub 2023 Aug 28.
Carbonell D, Mahajan S, Chee SP, Sobolewska B, Agrawal R, Bulow T, Gupta V, Jones NP, Accorinti M, Agarwal M, Batchelor T, Biswas J, Cimino L, tenDam-van Loon NH, de-la-Torre A, Frenkel S, Pe'er J, Kramer M, Miserocchi E, Mochizuki M, Ness T, Rosenbaum JT, Sen HN, Simion M (VRL patient), Sitter H, Vasconcelos-Santos DV, Habot-Wilner Z, Coupland SE, Pulido JS, Smith J, Thorne JE, Zierhut M; Study Group for Vitreoretinal Lymphoma Diagnostics. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2021 Apr 3;29(3):507-520. doi: 10.1080/09273948.2021.1878233. Epub 2021 May 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/2811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.